Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

ARRY: New 8K irt Genentech agreement. Expansion to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ThomasS Member Profile
 
Followed By 12
Posts 2,362
Boards Moderated 0
Alias Born 05/05/05
160x600 placeholder
S&P 500, Dow Close At Record Highs
The S&P 500 and Dow Jones Industrial Average closed at record levels on Thursday as investors welcomed the Federal Reserve's commitment to low interest rates long after the ending of monetary stimulus.
Top Equities Stories Of The Day
Newest iPhones Hit the Market Down Under
This Man's Job: Make Bill Gates Richer
U.S. Hot Stocks: Hot Stocks to Watch
Diageo Launches, Prices Euro Denominated Bonds
Senate Confirms Sheets as Treasury Under Secretary for International Affairs
Americans Support Striking Islamic Militants, Poll Shows
U.S. Hog Futures Fall Sharply on Supply Concerns, Cattle Decline
Continental Resources Names Insider as Chief Operating Officer
ThomasS   Monday, 09/08/08 07:36:58 AM
Re: None
Post # of 182052 
ARRY: New 8K irt Genentech agreement. Expansion to include a new target under the existing collaboration #msg-29627295:

Array BioPharma Inc. (the "Company") and Genentech, Inc. ("Genentech") have entered into an amendment effective as of September 1, 2008 (the "Amendment") to the Drug Discovery Collaboration Agreement between the Company and Genentech dated December 22, 2003, as amended (the "Agreement"). Under the Amendment, the Company and Genentech added a new collaboration target and agreed to increase the number of the Company's full-time equivalent scientists ("FTEs") performing services under the Agreement. Genentech continues to have the right to reduce the number of FTEs under the Agreement after January 1, 2010, subject to higher minimum levels set forth in the Amendment. The Amendment also provides for the payment of a one-time license fee, research funding and milestone payments to the Company in connection with the new target.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist